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A subset of monoamine neurons releases glutamate as a cotransmitter due to presence
of the vesicular glutamate transporters VGLUT2 or VGLUT3. In addition to mediating
vesicular loading of glutamate, it has been proposed that VGLUT3 enhances serotonin
(5-HT) vesicular loading by the vesicular monoamine transporter (VMAT2) in 5-HT
neurons. In dopamine (DA) neurons, glutamate appears to be released from specialized
subsets of terminals and it may play a developmental role, promoting neuronal growth
and survival. The hypothesis of a similar developmental role and axonal localization of
glutamate co-release in 5-HT neurons has not been directly examined. Using postnatal
mouse raphe neurons in culture, we first observed that in contrast to 5-HT itself, other
phenotypic markers of 5-HT axon terminals such as the 5-HT reuptake transporter
(SERT) show a more restricted localization in the axonal arborization. Interestingly, only
a subset of SERT- and 5-HT-positive axonal varicosities expressed VGLUT3, with SERT
and VGLUT3 being mostly segregated. Using VGLUT3 knockout mice, we found that
deletion of this transporter leads to reduced survival of 5-HT neurons in vitro and also
decreased the density of 5-HT-immunoreactivity in terminals in the dorsal striatum and
dorsal part of the hippocampus in the intact brain. Our results demonstrate that raphe
5-HT neurons express SERT and VGLUT3 mainly in segregated axon terminals and that
VGLUT3 regulates the vulnerability of these neurons and the neurochemical identity of
their axonal domain, offering new perspectives on the functional connectivity of a cell
population involved in anxiety disorders and depression.
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INTRODUCTION
Mounting evidence has accumulated in recent years demonstrating that a subset of monoamine
neurons including 5-HT, dopamine (DA) and epinephrine (E) and norepinephrine (NE) neurons
uses glutamate as a second neurotransmitter (Mestikawy et al., 2011; Hnasko and Edwards, 2012;
Trudeau et al., 2014; Zhang et al., 2015). In DA, E andNE neurons, glutamate packaging is mediated
by the type 2 vesicular glutamate transporter (VGLUT2; Stornetta et al., 2002; Dal Bo et al., 2004),
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while in serotonin (5-HT) neurons, this vesicular uptake is
mediated by VGLUT3 (Gras et al., 2002). Although in each of
these neuronal classes glutamate has been demonstrated to act as
a fast synaptic neurotransmitter (Sulzer et al., 1998; Varga et al.,
2009; Stuber et al., 2010; Tecuapetla et al., 2010; Holloway et al.,
2013), other roles of glutamate release by these neurons have
also been proposed. For example, VGLUT2-mediated glutamate
release has been proposed to play a critical developmental role in
DA neurons, contributing to axonal growth and to neuronal
survival (Fortin et al., 2012). VGLUT3 has also been suggested to
enhance the vesicular packaging of 5-HT in raphe neuron axon
terminals through a functional interaction between the vesicular
monoamine transporter (VMAT2) andVGLUT3 (Amilhon et al.,
2010), a mechanism of vesicular synergy first demonstrated
between VGLUT3 and the vesicular acetylcholine transporter
(VAChT; Gras et al., 2008). Whether such additional roles of
the glutamatergic co-phenotype are conserved across DA, 5-HT
and NE neurons is unclear. For example, it has not been directly
determined whether VGLUT3 contributes to development and
survival of 5-HT neurons.
It has been observed that a large proportion of central
5-HT neurons expresses VGLUT3 (Fremeau et al., 2002; Gras
et al., 2002; Schäfer et al., 2002; Takamori et al., 2002;
Hioki et al., 2010; Calizo et al., 2011; Kiyasova et al., 2013).
These neurons are most abundant in the dorsal and medial
raphe nuclei (DRN and MRN, respectively) and provide dense
5-HT innervation throughout the forebrain (particularly to the
striatum, lateral septum, dorsal and ventral hippocampus) and
brainstem (Dahlström and Fuxe, 1964). The distribution of
VGLUT3 in the axonal arborization of 5-HT neurons is unclear.
However, previous data argue for a heterogeneous distribution
in a subset of axon terminals established by 5-HT neurons.
For example, in the DRN, VGLUT3 has been reported to be
present in only a subset of axonal collaterals (Commons, 2009).
Similarly, in forebrain nuclei, only a variable proportion of
5-HT axonal fibers are reported to be VGLUT3-immunoreactive
(Shutoh et al., 2008). It has also been demonstrated that
5-HT axonal terminals expressing VGLUT3 are only rarely
co-labeled for the 5-HT reuptake transporter (SERT), a protein
often found in serotonergic axon terminals (Gras et al., 2002;
Amilhon et al., 2010). Due to the presence in most of
these regions of VGLUT3-immunoreactive axonal projections
originating from non-5-HT neurons, it remains unclear whether
the axonal arborization of individual 5-HT neurons contains
domains where VGLUT3 is segregated from typical 5-HT
neuron markers such as SERT, tryptophan hydroxylase (TrypH)
or 5-HT itself. Interestingly, qualitative evidence has been
previously provided suggesting the possibility of a partial
segregation of VGLUT3 and TrypH along the axonal domain
of embryonic rat raphe neurons in culture (Schäfer et al.,
2002).
In the present work, we aimed to address these outstanding
critical issues. We first used a postnatal mouse raphe neuron
culture model to examine the axonal arborization of individual
5-HT neurons to determine whether VGLUT3 is found at
release sites that are distinct from those containing 5-HT
or SERT. We also used this model to test the hypothesis
that, as suggested for VGLUT2 in DA neurons, VGLUT3
and glutamate release play a developmental role in 5-HT
neurons. We found that in vitro, the expression of SERT and
VGLUT3 was largely segregated in different axonal domains
of individual 5-HT neurons, a conclusion supported by the
finding that in vivo, these proteins are rarely colocalized.
Using a VGLUT3 knockout (KO) mouse line, we also
found that deletion of VGLUT3 increased the vulnerability
of 5-HT neurons in culture and reduced the density of
5-HT-immunoreactivity in terminals of both the dorsal striatum
and dorsal hippocampus.
MATERIALS AND METHODS
Animals
All procedures involving animals and their care were conducted
in accordance with the Guide to Care and Use of Experimental
Animals of the Canadian Council on Animal Care. The
experimental protocols were approved by the animal ethics
committees of the Université de Montréal.
All experiments were performed using wild type (WT) or
homozygous VGLUT3 KOmice obtained by crossing Vglut3−/+
mice (Gras et al., 2008). Mice were housed together in groups
of 2–4 per cage in a temperature-controlled room with a
12:12 h dark/light cycle. Food and water were provided ad
libitum. Age-matched WT littermates were used as controls
for VGLUT3 KO mice. Only males were used. Animals were
used between 45 and 75 days of age, except for the electron
microscopy experiments, where 15 and 60–70 day old mice were
compared.
Tissue Processing and Cell Culture
Postnatal day 0–3 (P0–P3) mice were cryoanesthetized and
decapitated for tissue collection. Primary cultures of raphe
5-HT neurons were prepared using a protocol identical to that
used to prepare mesencephalic neurons, as previously described
(Fasano et al., 2008). Raphe cells were plated onto monolayers of
astrocytes. Cultures were used for immunocytochemistry at 1, 3
or 7 days in vitro (DIV).
Immunocytochemistry on Cell Cultures
Cells were fixed with 4% paraformaldehyde (PFA),
permeabilized, and nonspecific binding sites blocked. To
identify 5-HT neurons and analyze their development,
a rabbit anti-5-HT antibody was used at a dilution of
1:2000 (Immunostar). The same rabbit anti-5HT antibody
was also used in combination with a monoclonal mouse
anti-microtubule associated protein 2 (MAP2) antibody
(1:2000, Sigma-Aldrich) to distinguish between the axons
and dendrites of 5-HT neurons. To study the segregation
of serotoninergic and glutamatergic terminals established
by 5-HT neurons, the rabbit anti-5-HT antibody was used
in combination with a goat anti-SERT antibody (1:1000;
C-20, Santa Cruz Biotechnology) and a guinea-pig anti-
VGLUT3 antibody (1:3000; Amilhon et al., 2010; Sakae et al.,
2015).
Frontiers in Neuroanatomy | www.frontiersin.org 2 April 2016 | Volume 10 | Article 39
Voisin et al. Segregation of Release Sites in Serotonin Neurons
Immunohistochemistry
Male mice were deeply anesthetized with chloral hydrate
(400 mg/kg, i.p.) and fixed by intracardiac perfusion using
150 ml of 4% PFA. The brain was removed, post-fixed by
immersion for 24–48 h in PFA solution at 4◦C, and washed
in phosphate-buffered saline (PBS; 0.9% NaCl in 50 mm
phosphate buffer, pH 7.4). Coronal 100 µm sections were cut
using a VT1000S vibrating microtome (Leica Microsystems).
Coronal sections were permeabilized, nonspecific binding sites
blocked and incubated overnight with rabbit anti-5HT antibody
(1:2000; Immunostar) in combination with goat anti-SERT
antibody (1:1000; C-20, Santa Cruz Biotechnology) and guinea-
pig anti-VGLUT3 antibody (1:3000; Amilhon et al., 2010; Sakae
et al., 2015); these were subsequently detected using FITC-
conjugated AffiniPure donkey anti-rabbit IgG, CY5-conjugated
AffiniPure donkey anti-goat IgG and CY3-conjugated AffiniPure
donkey anti-guinea-pig IgG (1:500; Jackson Immunoresearch).
Image Acquisition with Confocal
Microscopy
All of the in vitro and in vivo fluorescence imaging quantification
analyses were performed on images captured using confocal
microscopy. Images were acquired using an Olympus Fluoview
FV1000 confocal microscope (Olympus). Images acquired using
488, 546 and 633 nm laser excitation were scanned sequentially to
prevent nonspecific bleed-through signal. For the quantification
of 5-HT neuron survival, 21 coverslips from four different
cultures, fixed after 1 or 7 DIV, were acquired using a 20×
water immersion objective. For the in vitro quantification of
VGLUT3 expression in SERT neurons, five fields per coverslip
with at least two cell bodies were randomly selected. Images
were captured using a 20× water immersion objective from 12
coverslips coming from three different cultures at each time
points (1, 3 and 7 DIV). For the in vitro quantification of 5-
HT, SERT and VGLUT3 colocalization, 10 axonal fields per
coverslip were randomly selected. Images were captured using
a 60× oil-immersion objective from 12 coverslips coming from
three different cultures at each time points (1, 3 and 7 DIV).
For in vivo slice quantification, images were captured using a
60× oil-immersion objective from fields in the dorsal striatum,
lateral septum, hippocampus or raphe. For image acquisition in
the dorsal striatum and lateral septum, four random fields on
each side were taken from the left and the right hemisphere in
each section. For acquisition in the hippocampus, two fields were
selected from the left and the right hemisphere in each section.
For acquisition in the raphe, two fields were acquired from the
dorsal and medial sub-regions in each section.
Quantification of Confocal Images
All image quantification was performed using ImageJ (National
Institutes of Health) software. A threshold was first applied
at the same level for every image analyzed before performing
further analyses. This threshold was determined by measuring
the average background signal intensity and subtracted from the
analyzed signal. The values from five different 5-HT neurons
were averaged for each coverslip. At least 12 coverslips from three
different cultures for each DIV were used for all quantifications.
Quantifications of 5-HT- and VGLUT3-positive axon terminals
in dorsal striatum and lateral septum sections were performed
by averaging seven or eight images from seven different sections
in each mouse. For hippocampal sections, the analysis was
performed by averaging four images originating from six or seven
different sections per animal. For raphe sections, the analysis was
performed by averaging two images originating from six or seven
different sections per animal.
Double Fluorescence In Situ Hybridization
(FISH)
Antisense cRNA riboprobes were obtained from the
transcription of a PCR template amplified with primers
containing the T7 promoter followed by the serotonin
transporter (Slc6a4, SERT) sequence (forward primer
5′-AATTAACCCTCACTAAAGGGATGATGGTGACCAGTGT
GGTGAACTGCAT-3′ and reverse primer 5′-TAATACGACT
CACTATAGGGAGATCCATGAGAACAAACACGGG-3′) or
the VGLUT3 sequence (forward primer 5′-AATTAACCCTCA
CTAAAGGGAGAAAAACAGGACTGGGCTGACCC-3′ and
reverse primer 5′-TAATACGACTCACTATAGGGAGAGAGAC
CAAGGTCCATATTCCC-3′). SERT and VGLUT3 riboprobes
were labeled with UTPs coupled to fluorescein and
digoxigenin (DIG), respectively (Roche Applied Science).
Brainstem coronal cryosections (10 µm) were fixed with 4%
formaldehyde and hybridized as previously described (Gras
et al., 2002). Sections were incubated with anti-fluorescein
antiserum coupled with horseradish peroxidase (HRP; 1:250, 1 h
at room temperature (RT), Roche Applied Science). The signal
was amplified with the TSA-plus-biotin kit (Perkin Elmer).
VGLUT3 RNA was visualized with Neutravidin Oregon Green
(Invitrogen) at 488 nm excitation. After the HRP was inactivated
with a glycine solution, the brain slices were incubated in
the blocking solution for 30 min at RT. The slices were then
incubated with anti-DIG coupled with HRP (1:2500, Roche
Applied Science) for 1 h at RT. The TSA-plus-Cyanine 3 kit
(Perkin Elmer, 10 min at RT) was used to detect the SERT
transcript under 555 nm excitation fluorescence light. The
slices were mounted with Fluoromount-G (Southern Biotech),
scanned with a NanoZoomer 2.0-HT scanner (Hamamatsu
Photonics), digitized with version 2.3.27 NDP.scan and finally
visualized with NDP.view2. The number of SERT-positive
neurons was estimated on serial sections taken in the dorsal and
median raphe of VGLUT3WT (n = 5) or KO (n = 4) mice.
Stereological Analysis
Mice were perfused transcardially and brains were fixed in 4%
PFA and cryoprotected in 10% sucrose before cryosectioning
using a freezing microtome (Smith et al., 2003). Serial coronal
free-floating sections (40 µm thickness) of the raphe were
collected in an antifreeze solution. Sections were first rinsed
in 0.01 M PBS, then in 0.01 M PBS + 30% H2O2 and again
three times in 0.01 M PBS. Sections were then incubated in
rabbit 5-HT antibody (Immunostar) at a 1:2000 dilution (all
dilutionsmade in 0.3%Triton X-100/0.01 MPBS) for 48 h at 4◦C.
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After rinses in 0.01 M PBS (3 × 10 min), they were incubated
for 12 h at 4◦C in biotin-streptavidin conjugated AffiniPure
goat anti-rabbit IgG (1:200; Jackson Immunoresearch), washed
three times with 0.01 M PBS and then incubated for 3 h
at RT in streptavidin HRP conjugate (1:200; GE Healthcare).
Sections were visualized after 10 min 3,3′-diaminobenzidine
tetrahydrochloride (Sigma-Aldrich)/glucose oxidase reaction,
mounted on charged microscope slides in 0.1 M acetate buffer,
defatted using a series of ethanol and xylene baths and finally
coverslipped using Permount.
The number of 5-HT neurons in the raphe was analyzed
by unbiased stereological estimates. The total number of
5-HT neurons in the raphe was obtained by applying the
optical fractionator method (Gundersen et al., 1988) using
Stereo Investigator (version 6; MicroBrightField). In brief, the
rostrocaudal extent of the raphe was examined in 5-HT-
immunostained 40-µm thick coronal serial sections prepared
from 2-months old WT and KO VGLUT3 mice, with the
observer blind to the genotype. 5-HT-immunoreactive neurons
were counted in every sixth section at 100× magnification
using a 60 × 60 µm2 counting frame. The sections counted
corresponded to atlas levels −4.36, −4.48, −4.60, −4.72, −4.84
and −4.96 mm (240 µm interval) with respect to bregma
(Paxinos and Franklin, 2008). After immunohistochemistry,
mounting, defatting and coverslipping, the mean section
thickness, as measured with a z-axis microcator, was 12 µm. A
8 µm optical dissector was used with two 1 µm guard zones, and
counting sites were located at 100 µm intervals after a random
start.
Quantitative Colocalization Analysis
Quantitative colocalization analysis of 5-HT, SERT andVGLUT3
proteins was performed by quantifying the Mander’s overlap
coefficient (MOC) and overlap coefficientsM1 andM2 (Manders
et al., 1993). The MOC represents the degree of colocalization.
Overlap coefficientsM1 andM2 divide the value of colocalization
into two separate parameters. They reflect the percentage
of the total signal that colocalizes with each of the two
immunoreactive signals. In the present work, coefficient M1
indicated a contribution of the first protein indicated in the figure
caption, while coefficient M2 represented the contribution of the
second protein.
Electron Microscopy
In order to obtain an optimal compromise between
ultrastructural preservation and immunocytochemical detection,
we used in the present study a procedure for preparation
of mouse tissue for immunoelectron microscopy that was
previously described in detail (Bérubé-Carrière et al., 2009).
Briefly, mice were anesthetized with sodium pentobarbital
(80 mg/kg i.p.) and then fixed by intracardiac perfusion of a
solution of 3% acrolein in 0.1 M PBS (pH 7.4; 50 mL for P15
mice, 100 mL for adult mice) followed by 4% PFA in the same
buffer (100 mL for P15 mice, 150 mL for adult mice). The
brains were then removed, further fixed in 4% PFA for 1 h at
4◦C, and washed in PBS (0.9% NaCl in 50 mM PBS, pH 7.4).
Coronal sections, 50 µm thick, across the areas of interest were
then cut in cooled PBS with a vibrating microtome (VT100S;
Leica Microsystems), immersed in 0.1% sodium borohydride
(Sigma-Aldrich) in PBS for 30 min at RT, and washed in this
buffer before further processing.
For dual VGLUT3/SERT double-immunolabeling, five
VGLUT3 WT mice of immature (P15) and of adult ages were
used. Free-floating sections containing the striatum (around
0.14 mm anterior to bregma according to Paxinos and Franklin,
2008), lateral septum (around 0.14 mm anterior to bregma),
ventral hippocampus (around −2.92 mm anterior to bregma)
or dorsal hippocampus (around −1.64 mm anterior to bregma)
were selected. Sections were preincubated for 1 h at RT in
a blocking solution (PBS containing 5% normal goat serum
and 0.5% gelatin) to reduce nonspecific binding. They were
then incubated for 48 h in a 1:500 dilution of both primary
antibodies: polyclonal goat anti-SERT (C-20, Santa Cruz
Biotechnology) and polyclonal rabbit anti-VGLUT3 (Synaptic
Systems). After rinses in PBS (3 × 10 min), they were placed
overnight at RT in a 1:50 dilution of secondary immunogold
donkey anti-goat IgGs ultrasmall (ElectronMicroscopy Sciences)
and treated with HQ SilverTM Enhancement Kit (Nanoprobes)
for 10–15 min to increase the size of gold particles. The
immunogold-labeled sections were then incubated for 2 h in a
1:1000 dilution of biotinylated donkey anti-rabbit (for VGLUT3)
IgGs (Jakson Immunoresearch) in blocking solution. After
rinses in PBS (3 × 10 min), sections were incubated for 1 h
in a 1:1000 dilution of HRP-conjugated streptavidin (Jackson
Immunoresearch), washed in PBS and incubated for 2–5 min
in Tris-buffered saline (TBS) containing 3,3′-diaminobenzidine
tetrahydrochloride (0.05% DAB) and hydrogen peroxide
(0.02%). Immunocytochemical controls included processing
without either one or both primary antibodies. Only the expected
single labeling was observed after omitting one of the primary
antibody, and no labeling was detected in the absence of both
antibodies.
For single SERT immunolabeling, P15 and P60–70 VGLUT3
WT and KO mice were used (five animals per each age
and genotype). Free-floating sections containing the striatum
(around 0.14 mm anterior to bregma) were processed for
SERT immunohistochemistry with the same pre-embedding
immunogold technique described above.
All sections were further processed for electron microscopy
as extensively reported in previous publications (Bérubé-Carrière
et al., 2009, 2012). Briefly, sections were postfixed in 1% osmium
tetroxide for 30 min, dehydrated in ascending concentrations
of ethanol and flat embedded in Durcupan (Sigma-Aldrich)
between two sheets of Aclar plastic (EMS). After 48 h of
polymerization at 60◦C, the sheets were removed and specimens
from the areas of interest were excised and glued at the tip of resin
blocks. Ultrathin (70–80 nm) sections were then cut from the
surface of the blocks using a Reichart Ultracut S ultramicrotome
(Leica), collected on bare square-mesh copper grids and stained
with Reynold’s lead citrate.
Quantitative Analysis of Electron Microscopic Data
Five thin sections from each subregion were analyzed from each
animal. Only sections at the tissue-surface interface (less than
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10 µm away from the tissue-resin border) were selected for
analysis to avoid any differences in labeling due to differing
penetrance of reagents. The thin sections from each group were
examined at a working magnification of 13,500× under a CM100
electron microscope (Philips) equipped with an AMT camera
system (Advanced Microscopy Techniques). For the analysis
of gold particle distributions, an axon terminal profile was
considered to be positively labeled for SERT when it contained
three or more silver-intensified gold particles delineating the
axon terminal membrane. Smaller immunolabeled profiles were
assumed to represent intervaricose segments of unmyelinated
axons (Bérubé-Carrière et al., 2009). It should be pointed out
that peroxidase reaction product (labeling VGLUT3 in our study)
is typically not particulate but diffuse in nature, and thus not
easily confused with silver-enhanced immunogold products. The
acquired images were analyzed using the public domain ImageJ
software from NIH. In dual labeling experiments, the following
parameters were quantified for each brain subregion: (1) number
of gold-silver labeled varicosities (SERT positive); (2) number
of DAB-immunoreactive varicosities (VGLUT3 positive); and
(3) number of dually SERT/VGLUT3 labeled varicosities. In
simple labeling experiments evaluating SERT expression in the
striatum, long (L), short (s) axes and mean diameter (L+ s/2)
were measured for each immunogold-labeled varicosity. The
percentage of mitochondria was calculated as the total number
of mitochondria in all terminals divided by the examined surface
in total.
Statistics
Data are represented throughout as mean ± SEM. Statistically
significant differences were analyzed using Student’s t test, one-
way ANOVA or two-way ANOVA with post hoc Tukey tests, as
appropriate. AWhelch correction was applied when appropriate.
For immunoelectron microscopy experiments a Kruskal-Wallis
test was used when the data were found to not be normally
distributed. P-values below 0.05 were considered statistically
significant.
RESULTS
VGLUT3 is Found at SERT-Negative
Release Sites in Cultured 5-HT Neurons
We first examined the possibility of segregated glutamate release
sites in postnatal 5-HT neurons cultured from the dorso-median
part of the raphe of P0-P3 WT mice (Figure 1). Even as
early as 1 DIV, raphe 5-HT neurons displayed highly branched
MAP2-negative 5-HT-positive axonal processes with numerous
axonal-like varicosities (Figures 1A,B). Dendrites were both
MAP2- and 5-HT-positive (Figure 1A). A large majority of
raphe 5-HT neurons expressed SERT, while less than half were
immunopositive for VGLUT3 (Figures 1B,C). The proportion of
5-HT neurons expressing VGLUT3 remained constant at 1, 3 and
7 DIV and represented approximatively 40% of SERT-positive
neurons in culture (Figure 1D).
A closer examination of the localization of 5-HT, SERT
and VGLUT3 in the axonal arborization of cultured 5-HT
neurons revealed that 5-HT-immunoreactivity was detectable in
SERT-positive or VGLUT3-positive varicosities (Figures 2A,B).
However, strikingly, VGLUT3-positive and SERT-positive
axonal varicosities were frequently segregated (Figure 2C)
and a high proportion of VGLUT3-positive terminals were
thus essentially devoid of detectable SERT immunoreactivity.
A quantitative analysis of the colocalization of these signals
was performed by calculating the MOC (Figure 2D), as well
as the associated M1 and M2 coefficients (Supplementary
Figures S1A,B). The MOC displayed a gradual increase
across the three ages examined (DIV 1, 3 and 7; Figure 2D),
as reflected by a significant time effect in the two-way
ANOVA (F(2,99) = 11.99 and p = 0.0002). There was also a
significant difference between the three signals (5-HT/VGLUT3,
5-HT/SERT and SERT/VGLUT3; F(2,99) = 19.69 and p< 0.0001),
but no interaction (F(4,99) = 2.73 with p = 0.39). A Tukey multiple
comparison post hoc test showed that the 5-HT/SERT MOC
increased significantly at 7 DIV (MOC = 0.48) compared to
1 DIV (MOC = 0.25; p < 0.001) and to 3 DIV (MOC = 0.29;
p < 0.01), probably due to an age-dependent increase in the
levels of expression of SERT. We also found that VGLUT3
displayed a higher MOC with 5-HT than with SERT at 1
DIV (p < 0.01), 3 DIV (p < 0.01) and 7 DIV (p < 0.05)
and that SERT has a stronger MOC with 5-HT than with
VGLUT3 at 7 DIV (p < 0.01). The overlap coefficient M1
showed a time effect (F(2,99) = 6.35 and p = 0.002) but no
signal effect (F(2,99) = 2.93 and p < 0.06) and no interaction
(F(4,99) = 0.83 with p = 0.51; Supplementary Figure S1A).
A Tukey post hoc test showed that 5-HT contributed more
to colocalization with SERT at 7 DIV (M1 = 0.64) compared
to 3 DIV (M1 = 0.41; p < 0.05) and to 1 DIV (M1 = 0.39;
p < 0.05). Finally, overlap coefficient M2 showed a time effect
(F(2,99) = 3.6 and p = 0.03) and a signal effect (F(2,99) = 8.82
and p = 0.0003) but no interaction (F(4,99) = 1.00 with p = 0.41;
Supplementary Figure S1B). A Tukey post hoc test showed that
SERT contributed more to colocalization with 5-HT at 7 DIV
(M2 = 0.68) compared to 1 DIV (M2 = 0.46; p < 0.01). In
addition, SERT contributed more to colocalization with 5-HT
(M2 = 0.68) than VGLUT3 with SERT (M2 = 0.43) at 7 DIV
(p< 0.01).
VGLUT3 is Found at SERT-Negative
Release Sites in the Axonal Varicosities of
5-HT Neurons in the Intact Brain
We next evaluated if the limited colocalization of VGLUT3 and
SERT was also found in some of the specific projection areas of
5-HT neurons in the intact tissue (Figures 3A,B). We examined
brain sections from the dorsal striatum, lateral septum, dorsal
and ventral hippocampus and dorsal raphe, triple-labeled for
5-HT, VGLUT3 and SERT. Similarly to in vitro results, confocal
images revealed that 5-HT and SERT were highly colocalized
in axonal varicosities in the lateral septum (Figure 3C), dorsal
striatum (not shown), ventral (Figure 3D) and dorsal (not
shown) hippocampus. Similarly, 5-HT and VGLUT3 were also
colocalized in the lateral septum (Figure 3C) and ventral
hippocampus (Figure 3D) but less so in the dorsal parts
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FIGURE 1 | Expression of 5-HT reuptake transporter (SERT) and vesicular glutamate transporter (VGLUT3) in cultured serotonin (5-HT) neurons.
(A) Cultured 5-HT neurons display a highly developed axonal arborization, even after 1 day in vitro (DIV). Photomicrographs taken with a 20× magnification
illustrating 5-HT and microtubule associated protein 2 (MAP2) immunoreactivity. The white arows identify non-5-HT neurons. These illustrations show that axonal and
dendritic processes of 5-HT neurons are uniformly 5-HT immunoreactive. The orange arrows in the zoomed area (identified by the white box) show 5-HT neuron
dendrites, while the green arrows identify axonal domains of the same neuron. (B) Photomicrographs taken with a 20× magnification illustrating SERT positive
neurons expressing VGLUT3 at 1 DIV. (C) Photomicrographs taken with a 20× magnification illustrating SERT positive neurons expressing VGLUT3 at 7 DIV. (D) Bar
graph representing the proportion of SERT positive neurons expressing VGLUT3 protein at 1, 3 and 7 DIV. Scale bar = 100 µm (20× magnification) or 5 µm (crop).
of hippocampus and striatum. However, SERT and VGLUT3
proteins were mostly found in distinct axonal varicosities in all
of these projection areas.
To confirm these observations quantitatively, we analyzed
the MOC of 5-HT/SERT, 5-HT/VGLUT3 and SERT/VGLUT3
in images captured from these brain regions (Figures 3E–H).
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FIGURE 2 | SERT and VGLUT3 proteins are located at distinct axonal varicosities in cultured 5-HT neurons. (A) Photomicrograph of an axonal branch
from a 5-HT neuron at 1DIV, taken at 60× magnification. 5-HT (green), VGLUT3 (red) and SERT (blue) immunoreactivity is shown. (B) Photomicrograph for a similar
5-HT, VGLUT3, SERT triple-labeling from a 5-HT neuron at 7 DIV. (C) Cropped region identified by the while box in (B). As can be seen, while 5-HT signal is found
throughout the axonal segment, VGLUT3 and SERT are found only at a subset of axonal-like varicosities and are mostly segregated. The arrows show axon
terminals coexpressing 5-HT and VGLUT3 or 5-HT and SERT. (D) Bar graph representing Mander’s coefficient for the three signal combinations (5-HT/VGLUT3,
5-HT/SERT and SERT/VGLUT3) in cultured 5-HT neurons after 1, 3 and 7 DIV. The results show an increase over time of the colocalization between 5-HT and SERT
due to increased SERT signal over time. They also show that the colocalization of VGLUT3 with SERT is lower than with 5-HT. p < 0.05; δδ and p < 0.01;
∗∗∗p < 0.001. Scale bar = 50 µm (60× magnification) or 5 µm (crop).
Globally, the data show that the colocalization between SERT
and VGLUT3 was systematically lower compared to the
colocalization of either 5-HT/VGLUT3 or 5-HT/SERT. One-
way ANOVA analysis identified significant differences in the
MOC calculated from images obtained from the dorsal striatum
(F(2,96) = 69.34, p < 0.0001), lateral septum (F(2,90) = 68.27,
p < 0.0001), dorsal hippocampus (F(2,102) = 69.80, p < 0.0001)
and ventral hippocampus (F(2,87) = 67.36, p < 0.0001). For the
dorsal striatum (Figure 3E), a Tukey post hoc test showed that
the 5-HT/SERT MOC was larger than the SERT/VGLUT3 MOC
(p < 0.0001) and the 5-HT/VGLUT3 MOC (p < 0.0001). For
the lateral septum (Figure 3F), a Tukey post hoc test showed
that the 5-HT/SERT MOC was larger than the SERT/VGLUT3
MOC (p < 0.0001) or the 5-HT/VGLUT3 MOC (p < 0.0001).
In addition, the 5-HT/VGLUT3 MOC was higher than the
SERT/VGLUT3 MOC (p < 0.001). For the dorsal hippocampus
(Figure 3G), our data revealed that the 5-HT/SERT MOC
was larger than the SERT/VGLUT3 MOC (p < 0.0001)
or the 5-HT/VGLUT3 MOC (p < 0.0001). For the ventral
hippocampus (Figure 3H), we observed that the 5-HT/SERT
MOC was larger than the SERT/VGLUT3 MOC (p < 0.0001)
or the 5-HT/VGLUT3 MOC (p < 0.0001). Moreover, the
5-HT/VGLUT3MOCwas higher than the SERT/VGLUT3MOC
(p< 0.01).
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FIGURE 3 | SERT and VGLUT3 are located at distinct axonal varicosities of 5-HT neurons in intact brain tissue. (A) Schematic illustration representing the
location of different raphe nuclei and their projections. (B) Schematic illustrations of brain serotoninergic projection areas analyzed in the present study: lateral
septum, dorsal striatum, ventral and dorsal hippocampus. (C) Photomicrographs taken at 60× magnification showing 5-HT axonal varicosities immunolabeled for
(Continued)
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FIGURE 3 | Continued
5-HT, SERT and VGLUT3 in the lateral septum. (D) Photomicrographs taken
at 60× magnification showing 5-HT axonal varicosities immunolabeled for
5-HT, SERT and VGLUT3 in the ventral hippocampus. Axonal varicosities
expressing both 5-HT and VGLUT3 or 5-HT and SERT are designated by
arrows. (E–H) Bar graph representing Mander’s colocalization coefficient
calculated from images captured from the dorsal striatum, lateral septum,
dorsal and ventral hippocampus of P60 wild type (WT) mice. The data show
that the coefficient was lowest for the colocalization of VGLUT3 and SERT,
compatible with the observation that the two proteins are localized in different
axonal varicosities. ∗∗p < 0.01; ∗∗∗p < 0.001 and ∗∗∗∗p < 0.0001. Scale
bar = 50 µm (60× magnification) or 5 µm (crop).
Ultrastructural Evidence for Segregation of
VGLUT3 in Serotonergic Axon Terminals
To validate our observation of SERT/VGLUT3 segregation
with a higher resolution technique, we also examined the
localization of these two proteins in WT P15 and P60–70 mouse
brain using double-labeling immuno-electron microscopy.
Varicosities immunoreactive for SERT (immunogold labeling)
and/or VGLUT3 (immunoperoxidase-DAB labeling) were
examined in different brain regions at both ages (Figure 4). As
previously reported, SERT-gold particles were localized mainly
on the plasma membrane of labeled terminals (Descarries and
Riad, 2012). Serotoninergic terminals were found in all regions
explored (striatum, septum, ventral and dorsal hippocampus)
from both ages (P15 and P60). As expected, terminals were filled
with small, round or ovoid synaptic vesicles, often accompanied
by one or more mitochondria (Figure 4). Axon terminals
singly labeled for SERT or VGLUT3 were detected in all
brain regions examined, namely striatum, septum, ventral and
dorsal hippocampus. This was not the case for dually labeled
SERT/VGLUT3 varicosities, which were only infrequently
observed in the septum, ventral and dorsal hippocampus and
essentially absent from the striatum (Table 1). The number of
dually labeled varicosities was not statistically different between
immature and adult ages. However, the number of dually labeled
varicosities was significantly smaller compared to the number
of singly labeled VGLUT3 terminals. As shown in Table 1,
VGLUT3 was colocalized with SERT in a small proportion
of all VGLUT3-labeled axon terminals in P15 and P60 mice,
respectively representing 5.26% and 10.8% in the septum, 21.8%
and 13.4% in the ventral hippocampus, and finally 7.6% and
7.6% in the dorsal hippocampus. Dually labeled varicosities
were completely absent in the striatum of adult mice and were
exceedingly rare in immature ones.
FIGURE 4 | Ultrastructural evidence for segregation of VGLUT3 and SERT in serotonergic axon terminals. Low-magnification electron micrographs
illustrating SERT- (silver-intensified immunogold particles; thin arrows), VGLUT3- (fine diaminobenzidine (DAB) precipitate; arrowheads) or SERT/VGLUT3-
(silver-intensified immunogold particles associated with fine diaminobenzidine precipitate; thick black arrows) labeled axon terminals in immature (P15) (A–D) and
adult (P60) (E–H) wild-type (WT) mice of striatum (A,E), septum (B,F), ventral hippocampus (C,G) and dorsal hippocampus (D,H). m: mitochondria, ut: unlabeled
terminal. Magnification: 13,500× , Scale bar: 500 nm.
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TABLE 1 | Density of SERT, VGLUT3 and SERT/VGLUT3 axon terminals in immature and mature VGLUT3 WT mice.
Dorsal striatum Lateral septum Ventral Hipp Dorsal Hipp
P15 P60 P15 P60 P15 P60 P15 P60
Surface (µm2) 9612 6855.6 9184.8 10173.4 9754.4 7749.6 8828.8 8965.8
SERT 20.8 ± 2.1 18.6 ± 3.7 15 ± 1.7 26.4 ± 4.5 20.4 ± 3.7 26.7 ± 4.6 15 ± 3.6 22.2 ± 4.6
VGLUT3 77 ± 11.4 42.8 ± 5.2 50.4 ± 9.3 32.8 ± 6.2 24.4 ± 1.4 24 ± 7.08 38.8 ± 6.7 38.8 ± 8.2
SERT/VGLUT3 0.2 ± 0.2∗∗ 0 2.8 ± 1.2∗∗ 4 ± 1.7 6.8 ± 3.4∗∗ 3.7 ± 1.4 3.2 ± 1.4∗∗ 3.2 ± 1.2
Mean (± SEM) number of immunoreactive axon terminals per surface of thin sections examined in different brain regions after dual immunolabeling in WT mice at immature
(P15) or adult (P60–70) age (n = 5 mice per age). Statistical differences were calculated on the ratio of labeled terminals per examined surface. ∗∗p < 0.01 compared to
VGLUT3 in P15 mice; p < 0.05 compared to VGLUT3 in P60 mice.
The Glutamate Co-phenotype of 5-HT
Neurons Regulates the Vulnerability of
5-HT Neurons In Vitro
We next compared 5-HT neurons cultured from VGLUT3 KO
mice and WT littermates in order to test the hypothesis that the
glutamate co-phenotype of 5-HT neurons regulates their basal
vulnerability. A fixed number of neurons were cultured for 1 or 7
DIV, and then fixed and immunostained against 5-HT (data not
shown). The number of 5-HT-positive neurons after 1 and 7 DIV
was compared to quantify basal survival rate. The survival rate of
5-HT neurons was determined as the number of surviving 5-HT
neurons after 7 DIV compared to the number of surviving 5-HT
neurons after 1 DIV. We found that the survival rate of 5-HT
neurons prepared fromVGLUT3 KOmice was lower than that of
5-HT neurons fromWT littermates (36.59± 3.55% for VGLUT3
KO cultures compared to 51.82 ± 3.09% for WT cultures, t-test,
p = 0.002).
No Change in the Number of 5-HT Neurons
in the Brain of VGLUT3 KO Mice
The observed decrease in the basal survival of 5-HT neurons
in vitro suggests that loss of VGLUT3 leads to increased
vulnerability of these neurons. We next examined whether such
an increase in vulnerability was sufficient to lead to a reduced
number of 5-HT neurons in the intact brain. We counted SERT-
positive neurons in brain sections obtained from the DRN and
MRN of WT and VGLUT3 KO mice using fluorescent in situ
hybridization for SERT mRNA (Figure 5A). Compared to WT
littermate mice, the number of SERT-positive neurons in the
DRN of VGLUT3 KO mice was found to be unchanged (t-test;
1215 ± 35.37 (n = 5) for WT vs. 1206 ± 133.36 (n = 4) for KO
mice; p = 0.95; Figure 5B). In the MRN, the number of SERT-
positive neurons was also unchanged (t-test; 227.6± 31.18 (n= 5)
for WT mice vs. 195.0 ± 36.19 (n = 4) for KO mice; p = 0.51;
Figure 5B).
Unbiased stereological counting of the total population of
5-HT-immunoreactive neurons confirmed that deletion of the
VGLUT3 gene did not result in a reduced number of 5-HT
neurons in either the DRN or the MRN (Figure 5C). In DRN,
the estimated number of 5-HT-positive neurons using mean
section thickness was 14445 ± 2314 (n = 7) in WT mice vs.
10901± 2242 in VGLUT3 KOmice (n = 5; p = 0.31; Figure 5D).
In the MRN, the estimated number of 5-HT-positive neurons
using mean section thickness was 3789 ± 526.3 (n = 7) in WT
mice vs. 3289 ± 339.6 in VGLUT3 KO mice (n = 5; p = 0.49;
Figure 5D).
Reduced Density of 5-HT-Positive
Varicosities in VGLUT3 KO Brain Tissue
Although the number of 5-HT neurons was unchanged in
VGLUT3 KO mice, loss of VGLUT3 could have an impact on
the axonal arborization of 5-HT neurons, similarly to what has
previously shown in the absence of VGLUT2 in DA neurons
(Fortin et al., 2012). To examine this possibility, we performed
a 5-HT/SERT double-immunolabeling experiment to examine
the axonal processes of 5-HT neurons in WT and VGLUT3
KO mice in the dorsal striatum (Figure 6A), lateral septum,
dorsal hippocampus (Figure 6B) and ventral hippocampus.
We quantified total 5-HT (Figure 6C) and SERT (Figure 6D)
signal density by multiplying the mean signal intensity by the
signal area. Results were expressed relative to the signal density
of VGLUT3 WT mice. The density of 5-HT-immunoreactive
varicosities was significantly reduced in the dorsal striatum (t-
test, 100% ± 19.90 vs. 46.25% ± 8.52; p = 0.017) and dorsal
hippocampus (t-test, 100% ± 20.87 vs. 46.09 ± 7.96; p = 0.02)
of VGLUT3 KO mice compared to WT littermates, with a
similar tendency in the lateral septum (t-test, 100% ± 25.75
vs. 48.01 ± 11.01; p = 0.07) and no change in the ventral
hippocampus. The total density of SERT-immunoreactivity was
not significantly changed in the dorsal striatum, lateral septum
and dorsal hippocampus, but was increased in the ventral
hippocampus (t-test, 100% ± 13.97 vs. 153.4 ± 22.23; p = 0.047)
of VGLUT3 KO mice compared to WT littermates.
The Ultrastructural Features of SERT
Immunoreactive Axon Terminals are not
Altered in the Striatum of Immature and
Mature VGLUT3 KO Mice
To gain insight into the roles of VGLUT3 and glutamate
release in the structure of serotonergic axon terminals, we
next used immuno-electron microscopy to examine whether the
ultrastructural features of serotonergic terminals were modified
in the absence of VGLUT3. We focused our attention on the
striatum, the region showing the most extensive segregation of
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FIGURE 5 | The number of serotonin neurons is unchanged within the dorsal and median regions of the raphe nucleus in VGLUT3 KO mice.
(A) Photomicrographs taken at 20× and 60× magnifications, showing SERT mRNA in both dorsal and median raphe using fluorescent in situ hybridization for SERT
in VGLUT3 WT and KO mice. (B) Bar graphs illustrating the number of SERT- mRNA-containing neurons in the dorsal and median raphe of VGLUT3 WT and KO
mice. (C) Photomicrographs taken at 20× (left panels) and 60× (right panels) magnifications, showing 5-HT-immunoreactive neurons in both the dorsal and median
raphe, revealed by DAB staining, in VGLUT3 WT and KO mice. (D) Bar graphs illustrating the number of 5-HT neurons in the dorsal and median raphe of VGLUT3
WT and KO mice following unbiased stereological counting. Deletion of the VGLUT3 gene did not affect the number of 5-HT neurons in the dorsal and median
sub-regions of the raphe.
VGLUT3 and SERT. Striatal axon terminals labeled for SERT
exhibited similar size and shapes for both genotypes (Figure 7).
As mentioned previously, they typically contained synaptic
vesicles, often accompanied by mitochondria (Figure 7). SERT-
labeled terminals typically did not display a morphologically
defined area of synaptic membrane specialization, compatible
with previous work highlighting the mostly non-synaptic
nature of these release sites (Soghomonian et al., 1989). The
ultrastructural features of SERT singly labeled varicosities in
the striatum of immature (Figure 7A) and mature (Figure 7B)
mice are summarized in Table 2. Overall, the diameter of
SERT-labeled terminal profiles ranged from 0.47 ± 0.01 µm to
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FIGURE 6 | The density of 5-HT immunoreactive terminals is reduced in the forebrain and caudal hippocampus of VGLUT3 KO mice. (A,B)
Photomicrographs taken at 60× magnification, showing 5-HT immunoreactivity in the dorsal striatum (A) and dorsal hippocampus (B) of P60 VGLUT3 WT and KO
mice. (C,D) Bar graphs illustrating the density of 5-HT (C) and SERT (D) immunoreactivity (mean gray value × signal area) within the dorsal striatum, lateral septum,
dorsal and ventral hippocampus of P60 VGLUT3 WT and KO mice. Deletion of the VGLUT3 gene reduced the total density of 5-HT-positive varicosities in the dorsal
striatum and dorsal hippocampus. Finally, the total density of SERT immunoreactivity was unchanged in the forebrain and dorsal hippocampus, but increased in the
ventral hippocampus of VGLUT3 KO mice. Scale bar = 50 µm (60× magnification). ∗p < 0.05.
0.57 ± 0.03 µm, corresponding to an area of 0.14 ± 0.002 µm2
to 0.2 ± 0.02 µm2. The proportion of labeled terminals
containing one or more mitochondria ranged from 19.1 ± 2.1%
to 29.51± 2.3%. These parameters were not statistically different
between genotypes at the same age or across ages. Taken together,
those data indicate the absence of VGLUT3 was not associated
with a change in the morphological features of serotonergic axon
terminals in the striatum of mice.
DISCUSSION
Due to expression of VGLUT3, a subpopulation of raphe
5-HT neurons has the capacity to release glutamate. Studies
of VGLUT3 KO mice have previously suggested that vesicular
glutamate uptake in 5-HT neurons may have the capacity
to facilitate vesicular uptake of 5-HT and thus regulate
5-HT-dependent behavioral states such as anxiety (Amilhon
et al., 2010). However, the distribution and functional roles of
glutamate release sites by 5-HT neurons remain incompletely
characterized. In the present work, we further studied VGLUT3
in 5-HT neurons to address key outstanding issues. We provide
evidence that VGLUT3 is found in a subset of serotonergic
axon terminals that are mostly SERT-negative. Furthermore,
we find that loss of VGLUT3 is associated with an increase
in the basal vulnerability of 5-HT neurons in vitro, compatible
with a critical regulatory role of glutamate release in the
resilience of 5-HT neurons. We also report that deletion of
VGLUT3 leads to a reduced density of 5-HT-immunoreactive
axonal varicosities in projection areas of raphe 5-HT neurons,
which suggests a role of glutamate in regulating either the
axonal arborization of these neurons or the vesicular packaging
of 5-HT.
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FIGURE 7 | The ultrastructural features of SERT immunoreactive axon terminals are unchanged in the striatum of immature and mature VGLUT3 KO
mice. SERT immunoreactive axon terminals in the striatum of immature (P15) (A) and adult (P60) (B), wild-type (WT) and VGLUT3 knock-out (KO) mice, after
immunogold labeling for SERT. Terminals singly labeled for SERT (thin arrows) were observed for each age and genotype and found to be unchanged in size or in the
frequency at which they contain mitochondria. m, mitochondria; ut, unlabeled terminal. Magnification: 13,500×, Scale bar: 500 nm.
Heterogeneity of Axon Terminals
Established By 5-HT Neurons
The ability of 5-HT neurons to release glutamate was first
suggested over 20 years ago using patch-clamp recordings from
isolated rat 5-HT neurons in culture (Johnson, 1994). In more
recent studies, optogenetics was used to confirm that stimulation
of axonal fibers originating from mouse raphe 5-HT neurons
can induce fast glutamate-mediated postsynaptic currents in
CA1 hippocampal pyramidal neurons (Varga et al., 2009). This
glutamate release is mediated by the specific expression of
VGLUT3 in 5-HT neurons, as first suggested following the initial
cloning of the VGLUT3 gene and the mapping of the distribution
of its mRNA in select neuronal populations including raphe 5-
HT neurons (Fremeau et al., 2002; Gras et al., 2002). In an initial
qualitative study of the distribution of the VGLUT3 protein
in isolated rat 5-HT neurons in culture, it was reported that
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TABLE 2 | The structural features of SERT immunoreactive axon terminals
in the striatum of immature (P15) and mature (P60–70), VGLUT3 KO mice
are unaltered.
Dimensions
n No. Mean diameter (µm) Area (µm2) Mitochondria (%)
P15
WT 5 157 0.51 ± 0.04 0.17 ± 0.02 19.1 ± 2.1
KO 5 129 0.57 ± 0.03 0.2 ± 0.02 20.95 ± 3.6
P60
WT 5 157 0.47 ± 0.03 0.14 ± 0.01 26.85 ± 6.2
KO 5 152 0.47 ± 0.01 0.14 ± 0.002 29.51 ± 2.3
The table provides the mean diameter and the area of SERT-positive axon
terminals detected in striatal thin sections. The proportion of terminals containing
mitochondria was also calculated. Data are expressed as means ± SEM.
n, number of mice; No., number of axon terminals examined.
approximately half of the 5-HT neurons were immunopositive
for VGLUT3 (Fremeau et al., 2002). Furthermore, in VGLUT3-
positive 5-HT neurons, these authors reported the presence of
VGLUT3 in a majority of 5-HT-positive axonal-like varicosities.
A more recent study using a single-neuron tracing technique in
the adult rat suggested that all 5-HT neuronal cell bodies in the
dorsal raphe were VGLUT3-positive (Gagnon and Parent, 2014).
They also reported that a vast majority of the axonal varicosities
of 5-HT neurons in the striatum and pre-frontal cortex are co-
labeled with VGLUT3. In contrast, a previous study reported
that only a minority of 5-HT fibers in the adult rat ventral
midbrain are VGLUT3-positive (Martín-Ibañez et al., 2006). A
previous study also evaluated the distribution of VGLUT3, 5-
HT and SERT in projection areas of 5-HT neurons in the mouse
and reported that VGLUT3 was rarely associated with SERT
positive terminals in the lateral septum, prelimbic cortex and
hippocampus (Amilhon et al., 2010).
Our present findings confirm and extend previous reports
hypothesizing that the axonal varicosities of 5-HT neurons are
highly heterogeneous (Fremeau et al., 2002; Amilhon et al.,
2010). Our in vitro results provide strong data showing that
axonal-like varicosities established by individual 5-HT neurons
are neurochemically heterogeneous, with only a subset of 5-HT-
positive varicosities containing VGLUT3 or SERT. Furthermore,
we found that VGLUT3 and SERT were mostly segregated
in different sets of axonal-like varicosities. Our observation
that in brain sections, VGLUT3 and SERT are only rarely
colocalized, also argues in favor of the hypothesis of segregated
release sites. However, additional experiments using techniques
to label the axonal domain of single 5-HT neurons will be
required to fully confirm this model in vivo. Our in vitro
data demonstrating such segregation are compatible with earlier
work first suggesting such heterogeneity (Amilhon et al., 2010).
Our work showing that only approximately half of 5-HT
neurons express VGLUT3 are also compatible with earlier work
(Fremeau et al., 2002). The rarity of SERT/VGLUT3 dually-
labeled endings, confirmed by our immuno-electron microscopy
results, reinforces the hypothesis of the existence of a subset of
5-HT terminals displaying enhanced extracellular 5-HT levels
after release due to weak 5-HT reuptake and enhanced vesicular
packaging of 5-HT in VGLUT3-positive serotonergic terminals
(Mestikawy et al., 2011). These findings however stand in
relative contrast to previous work suggesting that essentially
all raphe 5-HT neurons contain VGLUT3 and that almost
all of their terminals in the striatum and cortex also contain
the protein (Gagnon and Parent, 2014). The reason for this
discrepancy remains unclear at the present time. Other than
technical issues related to antibody specificity and sensitivity,
one possibility is that the relative proportion of 5-HT terminals
containing VGLUT3 may depend on the species used. Here, we
examined the axonal distribution of 5-HT, SERT and VGLUT3
in the mouse, whereas Gagnon and Parent (2014) evaluated
rat tissue. It is therefore possible that VGLUT3 is expressed
more extensively and broadly in rat compared to mouse 5-
HT neurons. Interestingly, in the P15 rat, VGLUT2 is found
to be more frequently colocalized with dopaminergic markers
such as tyrosine hydroxylase than in the mouse, also illustrating
species differences in vesicular glutamate transporter localization
in monoamine neurons (Bérubé-Carrière et al., 2009, 2012).
Importantly, our finding of segregation of VGLUT3 and SERT
in 5-HT neurons is compatible with a similar segregation of
VGLUT2 and dopaminergic markers in DA neurons (Fortin
et al., 2012; Zhang et al., 2015). Our results are also compatible
with previous work also arguing for neurotransmitter segregation
in other classes of neurons throughout the nervous system
(Sámano et al., 2012). Similar segregation has for example been
observed in the invertebrate nervous system (Sossin et al., 1990),
in mammalian motor neurons (Nishimaru et al., 2005), in
neurons of the bed nucleus of the stria terminalis projecting to
the ventral tegmental area (Kudo et al., 2012), in sympathetic
ganglia (Sámano et al., 2009) and in startburst amacrine cells
of retina (Lee et al., 2010). Interestingly, previous work suggests
that neurotransmitter segregation is not a fixed or invariable
characteristic of neurons, but rather is a plastic phenomenon that
can be influenced by the synaptic environment or by signals such
as trophic factors (Vega et al., 2010, 2015).
The segregation of VGLUT3 and SERT that we observed here
could potentially underlie differential release of glutamate and 5-
HT from different terminals established by 5-HT raphe neurons.
They might use glutamate as transmitter at VGLUT3 positive
varicosities and serotonin at SERT positive varicosities and the
release of one or the other transmitter could be differentially
regulated under certain conditions. Transmitters segregation
may confer to neurons the capability to specifically change the
function of single endings following plastic experiences (Sámano
et al., 2012).
Finally, it is important to consider that regions such as
the striatum or hippocampus also contain VGLUT3-positive
terminals that originate respectively from cholinergic neurons
of the striatum or GABAergic interneurons of the hippocampus
(Fremeau et al., 2002; Gras et al., 2002; Boulland et al., 2004). In
particular, Boulland et al. (2004) used immunofluorescence and
confocal microscopy to reveal partial co-expression of VGLUT3
and VGAT, the vesicular GABA transporter, in terminals close
to pyramidal cells and granule cells in the rat hippocampus,
with an increase of such co-expression during development.
Interestingly, they also showed that during the early postnatal
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period in the rat, some VMAT2-positive/TH-negative terminals
in the hippocampus co-express VGLUT3, suggesting that they
represent 5-HT terminals. The detection of such terminals as
VGLUT3-positive but SERT-negative in our experiments is likely
to have contributed to the relative rarity of SERT/VGLUT3
terminals, but even considering this, it remains clear that SERT-
positive terminals also containing VGLUT3 are the exception
rather than the norm in the mouse brain.
Although further work will be required to test this
hypothesis, it is possible that the segregated expression of
VGLUT3 and SERT in 5-HT terminals may be accompanied
by morphological heterogeneity of the axon terminals. For
example, we hypothesize that VGLUT3-positive endings may be
synaptic in structure whereas VGLUT3-negative/SERT-positive
or VGLUT3-negative/SERT-negative 5-HT terminals may be
asynaptic (Umbriaco et al., 1995; Parent et al., 2010; Mestikawy
et al., 2011). Our present finding that essentially all SERT-positive
axonal varicosities visualized by electron microscopy failed to
show a synaptic specialization is compatible with this hypothesis.
Interestingly, in the rat, it has been demonstrated that the 5-HT
terminals expressing SERT in the cortex and ventral striatum
were preferentially fusiform while the SERT negative terminals
were larger and more spherical (Kosofsky and Molliver, 1987).
Impact of VGLUT3 Gene Deletion on
Serotonergic Axon Terminals
5-HT neurons regulate several neuronal and physiological
functions like anxiety, mood, aggressive behavior, nociception,
circadian rhythm as well as appetitive and sexual behaviors.
Recently, Amilhon and collaborators (Amilhon et al., 2010)
reported that deletion of the VGLUT3 gene in mouse leads to
anxiety-like behaviors, a behavioral phenotype they attributed to
reduced 5-HT vesicular packaging secondary to loss of VGLUT3.
Our data showing reduced 5-HT immunoreactivity in the
dorsal striatum and dorsal hippocampus of VGLUT3 KO mice
support this hypothesis. The reduced 5-HT immunoreactivity
we detected in the present study could be due to either of
two possible mechanisms. First, this could be due to reduced
concentrations of 5-HT in serotonergic axon terminals due
to reduced vesicular packaging, as per the vesicular synergy
hypothesis (Gras et al., 2008; Amilhon et al., 2010). Second,
this could be due to an impaired axonal development of 5-
HT neurons, perhaps similar to the impairment of axonal
growth reported in DA neurons after selective deletion of the
VGLUT2 gene (Fortin et al., 2012). Our in vitro results showing
no impairment or axonal (Supplementary Figures S2A,C) or
dendritic (Supplementary Figures S2B,D) growth in 5-HT
neurons in the absence of VGLUT3 argue in favor of the first
hypothesis.
We found that 5-HT immunoreactivity was not significantly
decreased in the lateral septum and ventral hippocampus in
VGLUT3 KO mice. Moreover, this was associated with an
increased density of SERT immunoreactivity in the ventral
hippocampus. Selective upregulation of SERT expression in the
ventral, but not in the dorsal part of hippocampus of VGLUT3
KO mice might suggest that hippocampal SERT transporters
vary in their adaptability to changes in 5-HT tone along the
dorsoventral axis. The reason for this differential effect in the
ventral hippocampus is presently unclear. The density of 5-HT
innervation in this structure was lower than the other brain
regions examined. This could have led to increased variability of
the measurements and reduced statistical power. Alternately, up-
regulation of SERT in the ventral hippocampus could represent a
paradoxical compensatory response to low 5-HT levels (Hamon
et al., 1981).
The lack of changes in the density or ultrastructure of
SERT-positive varicosities observed here could reflect the fact
that loss of VGLUT3 in 5-HT neurons did not lead to a
developmental reduction of the growth capacity of serotonergic
terminals, as suggested by our in vitro results. Rather, the
reduced density of 5-HT immunoreactivity could reflect reduced
vesicular packaging of 5-HT, due to loss of vesicular synergy.
Further work will be required to demonstrate this, such as by
tracing the axonal arborization of individual 5-HT neurons in
vivo using virally-encoded tracers.
Our in vitro comparison of the basal survival of 5-HT neurons
in VGLUT3 KO cultures revealed reduced survival compared
to WT littermate controls. These findings, suggesting increased
vulnerability, are compatible with a similar observation made for
DA neurons after deletion of the VGLUT2 gene (Fortin et al.,
2012). These results suggest the possibility that glutamate release
may play a pro-survival role in monoamine neurons in general.
However, considering our finding of a lack of decrease in the
number of 5-HT neurons in the MRN and DRN of VGLUT3
KO mice, as determined by unbiased stereological counting and
fluorescent in situ hybridization, our in vitro observations suggest
the possibility that although basal survival may be unchanged
in VGLUT3 KO mice, 5-HT neurons in these animals may
be more vulnerable to cellular stress, such as in the context
of Parkinson’s disease, a pathology in which a subset of 5-HT
neurons are lost in addition to DA neurons. Further experiments
evaluating the vulnerability of 5-HT neurons to neurotoxins such
as 5,7-dihydroxytryptamine would help to further address this
possibility.
In conclusion, our data provide strong support for the
hypothesis that 5-HT neurons express a highly heterogeneous set
of axon terminals, only a subset of which contains VGLUT3 or
SERT. The almost complete segregation of SERT and VGLUT3
is compatible with the possibility that this morphological
heterogeneity is associated with a functional heterogeneity such
that terminals expressing VGLUT3 but not SERT may be sites
of elevated 5-HT neurotransmission due to increased vesicular
packaging and reduced extracellular reuptake. These findings
offer a new perspective on the functional connectivity of a cell
population involved in brain diseases such as anxiety disorders
and depression. Further work will be required to determine
whether changes in the expression and localization of VGLUT3
in 5-HT neurons are associated with disease.
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SUPPLEMENTARY FIGURE S1 | SERT and VGLUT3 proteins are
located at distinct axonal varicosities in cultured 5-HT neurons. (A) Bar
graph representing the overlap coefficient M1 for the three signal
combinations (5-HT/VGLUT3, 5-HT/SERT and SERT/VGLUT3) in cultured
5-HT neurons after 1, 3 and 7 DIV. The results show an increase over time of
the colocalization between 5-HT and SERT due to increased 5-HT signal over
time. (B) Bar graph representing the overlap coefficient M2 for the three signal
combinations (5-HT/VGLUT3, 5-HT/SERT and SERT/VGLUT3) in cultured
5-HT neurons after 1, 3 and 7 DIV. The results show an increase over time of
the colocalization between 5-HT and SERT starting from 3 DIV due to
increased SERT signal over time. They also show that the colocalization of
VGLUT3 with SERT is lower than with 5-HT. ∗(compared to 1 DIV) and
δ(compared to 3 DIV) p < 0.05; δδ and p < 0.01.
SUPPLEMENTARY FIGURE S2 | Deletion of the VGLUT3 gene does not
alter the axonal and dendritic morphology of cultured 5-HT neurons.
(A) Bar graphs illustrating the number of processes and total length of axonal
processes of cultured 5-HT neurons from VGLUT3 WT and KO mice after 1
DIV. (B) Bar graphs illustrating the number of processes and total length of
dendritic processes of cultured 5-HT neurons from VGLUT3 WT and KO mice
after 1 DIV. (C) Bar graphs illustrating the number of processes and total
length of axonal processes of cultured 5-HT neurons from VGLUT3 WT and
KO mice after 7 DIV. (D) Bar graphs illustrating the number of processes and
total length of dendritic processes of cultured 5-HT neurons from VGLUT3 WT
and KO mice after 7 DIV.
REFERENCES
Amilhon, B., Lepicard, E., Renoir, T., Mongeau, R., Popa, D., Poirel, O., et al.
(2010). VGLUT3 (vesicular glutamate transporter type 3) contribution to the
regulation of serotonergic transmission and anxiety. J. Neurosci. 30, 2198–2210.
doi: 10.1523/jneurosci.5196-09.2010
Bérubé-Carrière, N., Guay, G., Fortin, G. M., Kullander, K., Olson, L., Wallén-
Mackenzie, Å, et al. (2012). Ultrastructural characterization of the mesostriatal
dopamine innervation in mice, including two mouse lines of conditional
VGLUT2 knockout in dopamine neurons. Eur. J. Neurosci. 35, 527–538. doi: 10.
1111/j.1460-9568.2012.07992.x
Bérubé-Carrière, N., Riad, M., Dal Bo, G., Lévesque, D., Trudeau, L. E., and
Descarries, L. (2009). The dual dopamine-glutamate phenotype of growing
mesencephalic neurons regresses in mature rat brain. J. Comp. Neurol. 517,
873–891. doi: 10.1002/cne.22194
Boulland, J. L., Qureshi, T., Seal, R. P., Rafiki, A., Gundersen, V., Bergersen,
L. H., et al. (2004). Expression of the vesicular glutamate transporters during
development indicates the widespread corelease of multiple neurotransmitters.
J. Comp. Neurol. 480, 264–80. doi: 10.1002/cne.20354
Calizo, L. H., Akanwa, A., Ma, X., Pan, Y. Z., Lemos, J. C., Craige, C., et al.
(2011). Raphe serotonin neurons are not homogenous: electrophysiological,
morphological and neurochemical evidence. Neuropharmacology 61, 524–543.
doi: 10.1016/j.neuropharm.2011.04.008
Commons K. G. (2009). Locally collateralizing glutamate neurons in the
dorsal raphe nucleus responsive to substance P contain vesicular glutamate
transporter 3 (VGLUT3). J. Chem. Neuroanat. 38, 273–281. doi: 10.1016/j.
jchemneu.2009.05.005
Dahlström, A., and Fuxe, K. (1964). Localization ofmonoamines in the lower brain
stem. Experientia 20, 398–399. doi: 10.1007/bf02147990
Dal Bo, G., St-Gelais, F., Danik, M., Williams, S., Cotton, M., Trudeau,
L. E., et al. (2004). Dopamine neurons in culture express VGLUT2
explaining their capacity to release glutamate at synapses in addition to
dopamine. J. Neurochem. 88, 1398–1405. doi: 10.1046/j.1471-4159.2003.
02277.x
Descarries, L., and Riad, M. (2012). Effects of the antidepressant fluoxetine on the
subcellular localization of 5-HT1A receptors and SERT. Philos. Trans. R. Soc.
Lond. B Biol. Sci. 367, 2416–2425. doi: 10.1098/rstb.2011.0361
Fasano, C., Thibault, D., and Trudeau, L. E. (2008). Culture of postnatal
mesencephalic dopamine neurons on an astrocyte monolayer. Curr. Protoc.
Neurosci. 3:Unit 3.21. doi: 10.1002/0471142301.ns0321s44
Fortin, G. M., Bourque, M. J., Mendez, J. A., Leo, D., Nordenankar, K., Birgner, C.,
et al. (2012). Glutamate corelease promotes growth and survival of midbrain
dopamine neurons. J. Neurosci. 32, 17477–17491. doi: 10.1523/jneurosci.1939-
12.2012
Fremeau, R. T., Burman, J., Qureshi, T., Tran, C. H., Proctor, J., Johnson, J., et al.
(2002). The identification of vesicular glutamate transporter 3 suggests novel
modes of signaling by glutamate. Proc. Natl. Acad. Sci. U S A. 99, 14488–14493.
doi: 10.1073/pnas.222546799
Gagnon, D., and Parent, M. (2014). Distribution of VGLUT3 in highly
collateralized axons from the rat dorsal raphe nucleus as revealed by
single-neuron reconstructions. PLoS One 9:e87709. doi: 10.1371/journal.pone.
0087709
Gras, C., Amilhon, B., Lepicard, E. M., Poirel, O., Vinatier, J., Herbin, M.,
et al. (2008). The vesicular glutamate transporter VGLUT3 synergizes striatal
acetylcholine tone. Nat. Neurosci. 11, 292–300. doi: 10.1038/nn2052
Gras, C., Herzog, E., Bellenchi, G. C., Bernard, V., Ravassard, P., Pohl, M., et al.
(2002). A third vesicular glutamate transporter expressed by cholinergic and
serotoninergic neurons. J. Neurosci. 22, 5442–5451.
Gundersen, H. J., Bagger, P., Bendtsen, T. F., Evans, S. M., Korbo, L.,
Marcussen, N., et al. (1988). The new stereological tools: disector, fractionator,
nucleator and point sampled intercepts and their use in pathological research
and diagnosis. APMIS 96, 857–881. doi: 10.1111/j.1699-0463.1988.tb00954.x
Hamon, M., Bourgoin, S., Artaud, F., and Mestikawy, S. (1981). The respective
roles of tryptophan uptake and tryptophan hydroxylase in the regulation
of serotonin synthesis in the central nervous system. J. Physiol. Paris 77,
269–279.
Hioki, H., Nakamura, H., Ma, Y. F., Konno, M., Hayakawa, T., Nakamura, K. C.,
et al. (2010). Vesicular glutamate transporter 3-expressing nonserotonergic
projection neurons constitute a subregion in the rat midbrain raphe nuclei.
J. Comp. Neurol. 518, 668–686. doi: 10.1002/cne.22237
Hnasko, T. S., and Edwards, R. H. (2012). Neurotransmitter corelease: mechanism
and physiological role. Annu. Rev. Physiol. 74, 225–243. doi: 10.1146/annurev-
physiol-020911-153315
Holloway, B. B., Stornetta, R. L., Bochorishvili, G., Erisir, A., Viar, K. E., Guyenet,
P. G., et al. (2013). Monosynaptic glutamatergic activation of locus coeruleus
and other lower brainstem noradrenergic neurons by the C1 cells in mice.
J. Neurosci. 33, 18792–18805. doi: 10.1523/jneurosci.2916-13.2013
Johnson, M. D. (1994). Synaptic glutamate release by postnatal rat serotonergic
neurons in microculture. Neuron 12, 433–442. doi: 10.1016/0896-
6273(94)90283-6
Frontiers in Neuroanatomy | www.frontiersin.org 16 April 2016 | Volume 10 | Article 39
Voisin et al. Segregation of Release Sites in Serotonin Neurons
Kiyasova, V., Bonnavion, P., Scotto-Lomassese, S., Fabre, V., Sahly, I., Tronche, F.,
et al. (2013). A subpopulation of serotonergic neurons that do not express the
5-HT1A autoreceptor. ACS Chem. Neurosci. 4, 89–95. doi: 10.1021/cn300157s
Kosofsky, B. E., and Molliver, M. E. (1987). The serotoninergic innervation of
cerebral cortex: different classes of axon terminals arise from dorsal andmedian
raphe nuclei. Synapse 1, 153–168. doi: 10.1002/syn.890010204
Kudo, T., Uchigashima, M., Miyazaki, T., Konno, K., Yamasaki, M., Yanagawa, Y.,
et al. (2012). Three types of neurochemical projection from the bed nucleus of
the stria terminalis to the ventral tegmental area in adult mice. J. Neurosci. 32,
18035–18046. doi: 10.1523/jneurosci.4057-12.2012
Lee, S., Kim, K., and Zhou, Z. J. (2010). Role of ACh-GABA cotransmission in
detecting image motion and motion direction. Neuron 68, 1159–1172. doi: 10.
1016/j.neuron.2010.11.031
Manders, E. M. M., Verbeek, F. J., and Aten, J. A. (1993). Measurement of co-
localization of objects in dual-colour confocal images. J. Micros. 169, 375–382.
doi: 10.1111/j.1365-2818.1993.tb03313.x
Martín-Ibañez, R., Jenstad, M., Berghuis, P., Edwards, R. H., Hioki, H., Kaneko, T.,
et al. (2006). Vesicular glutamate transporter 3 (VGLUT3) identifies spatially
segregated excitatory terminals in the rat substantia nigra. Eur. J. Neurosci. 23,
1063–1070. doi: 10.1111/j.1460-9568.2006.04601.x
Mestikawy, S. El, Wallén-Mackenzie, A., Fortin, G. M., Descarries, L., and
Trudeau, L. E., (2011). From glutamate co-release to vesicular synergy: vesicular
glutamate transporters. Nat. Rev. Neurosci. 12, 204–216. doi: 10.1038/nrn2969
Nishimaru, H., Restrepo, C. E., Ryge, J., Yanagawa, Y., and Kiehn, O. (2005).
Mammalian motor neurons corelease glutamate and acetylcholine at central
synapses. Proc. Natl. Acad. Sci. U S A 102, 5245–5249. doi: 10.1073/pnas.
0501331102
Parent, M., Wallman, M. J., Descarries, L. (2010). Distribution and ultrastructural
features of the serotonin innervation in rat and squirrel monkey subthalamic
nucleus. Eur. J. Neurosci. 31, 1233–1242. doi: 10.1111/j.1460-9568.2010.
07143.x
Paxinos, G., and Franklin, K. B. (2008). The Mouse Brain in Stereotaxic
Coordinates, 3rd edition. (New York, NY: Elsevier).
Sakae, D. Y., Marti, F., Lecca, S., Vorspan, F., Martín-García, E., Morel, L. J., et al.
(2015). The absence of VGLUT3 predisposes to cocaine abuse by increasing
dopamine and glutamate signaling in the nucleus accumbens. Mol. Psychiatry
20, 1448–1459. doi: 10.1038/mp.2015.104
Sámano, C., Cifuentes, F., and Morales, M. A. (2012). Neurotransmitter
segregation: functional and plastic implications. Prog. Neurobiol. 97, 277–287.
doi: 10.1016/j.pneurobio.2012.04.004
Sámano, C., Zetina, M. E., Cifuentes, F., and Morales, M. A. (2009). Segregation
of met-enkephalin from vesicular acetylcholine transporter and choline
acetyltransferase in sympathetic preganglionic varicosities mostly lacking
synaptophysin and synaptotagmin. Neuroscience 163, 180–189. doi: 10.1016/j.
neuroscience.2009.06.010
Schäfer, M. K., Varoqui, H., Defamie, N., Weihe, E., and Erickson, J. D. (2002).
Molecular cloning and functional identification of mouse vesicular glutamate
transporter 3 and its expression in subsets of novel excitatory neurons. J. Biol.
Chem. 277, 50734–50748. doi: 10.1074/jbc.m206738200
Shutoh, F., Ina, A., Yoshida, S., Konno, J., and Hisano, S. (2008). Two distinct
subtypes of serotonergic fibers classified by co-expression with vesicular
glutamate transporter 3 in rat forebrain. Neurosci. Lett. 432, 132–136. doi: 10.
1016/j.neulet.2007.12.050
Smith, P. D., Crocker, S. J., Jackson-Lewis, V., Jordan-Sciutto, K. L., Hayley,
S., Mount, M. P., et al. (2003). Cyclin-dependent kinase 5 is a mediator of
dopaminergic neuron loss in a mouse model of Parkinson’s disease. Proc. Natl.
Acad. Sci. U S A. 100, 13650–13655. doi: 10.1073/pnas.2232515100
Soghomonian, J. J., Descarries, L., and Watkins, K. C. (1989). Serotonin
innervation in adult rat neostriatum. Brain Res. 481, 67–86.
Sossin, W. S., Sweet-Cordero, A., and Scheller, R. H. (1990). Dale’s hypothesis
revisited: different neuropeptides derived from a common prohormone are
targeted to different processes. Proc. Natl. Acad. Sci. U S A. 87, 4845–4848.
Stornetta, R. L., Sevigny, C. P., and Guyenet, P. G. (2002). Vesicular glutamate
transporter DNPI/VGLUT2mRNA is present in C1 and several other groups of
brainstem catecholaminergic neurons. J. Comp. Neurol. 444, 191–206. doi: 10.
1002/cne.10141
Stuber, G. D., Hnasko, T. S., Britt, J. P., Edwards, R. H., and Bonci, A. (2010).
Dopaminergic terminals in the nucleus accumbens but not the dorsal striatum
corelease glutamate. J. Neurosci. 30, 8229–8233. doi: 10.1523/jneurosci.1754-10.
2010
Sulzer, D., Joyce, M. P., Lin, L., Geldwert, D., Haber, S. N., Hattori, T., et al.
(1998). Dopamine neurons make glutamatergic synapses in vitro. J. Neurosci.
18, 4588–4602.
Takamori, S., Malherbe, P., Broger, C., and Jahn, R. (2002). Molecular cloning and
functional characterization of human vesicular glutamate transporter 3. EMBO
Rep. 3, 798–803. doi: 10.1093/embo-reports/kvf159
Tecuapetla, F., Patel, J. C., Xenias, H., English, D., Tadros, I., Shah, F., et al.
(2010). Glutamatergic signaling by mesolimbic dopamine neurons in the
nucleus accumbens. J. Neurosci. 30, 7105–7110. doi: 10.1523/jneurosci.0265-10.
2010
Trudeau, L. E., Hnasko, T. S., Wallén-Mackenzie, A., Morales, M., Rayport, S., and
Sulzer, D. (2014). The multilingual nature of dopamine neurons. Prog. Brain
Res. 211, 141–164. doi: 10.1016/b978-0-444-63425-2.00006-4
Umbriaco, D., Garcia, S., Beaulieu, C., and Descarries, L. (1995). Relational
features of acetylcholine, noradrenaline, serotonin and GABA axon terminals
in the stratum radiatum of adult rat hippocampus (CA1). Hippocampus 5,
605–620.
Varga, V., Losonczy, A., Zemelman, B. V., Borhegyi, Z., Nyiri, G., Domonkos, A.,
et al. (2009). Fast synaptic subcortical control of hippocampal circuits. Science
326, 449–453. doi: 10.1126/science.1178307
Vega, A., Cancino-Rodezno, A., Valle-Leija, P., Sánchez-Tafolla, B. M., Elinos,
D., Cifuentes, F., et al. (2015). Neurotrophin-dependent plasticity of
neurotransmitter segregation in the rat superior cervical ganglion in vivo. Dev.
Neurobiol. doi: 10.1002/dneu.22362 [Epub ahead of print].
Vega, A., Luther, J. A., Birren, S. J., and Morales, M. A. (2010). Segregation of the
classical transmitters norepinephrine and acetylcholine and the neuropeptide
Y in sympathetic neurons: modulation by ciliary neurotrophic factor or
prolonged growth in culture. Dev. Neurobiol. 70, 913–928. doi: 10.1002/dneu.
20834
Zhang, S., Qi, J., Li, X., Wang, H. L., Britt, J. P., Hoffman, A. F., et al.
(2015). Dopaminergic and glutamatergic microdomains in a subset of rodent
mesoaccumbens axons. Nat. Neurosci. 18, 386–392. doi: 10.1038/nn.3945
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2016 Voisin, Mnie-Filali, Giguère, Fortin, Vigneault, El Mestikawy,
Descarries and Trudeau. This is an open-access article distributed under the terms
of the Creative Commons Attribution License (CC BY). The use, distribution and
reproduction in other forums is permitted, provided the original author(s) or licensor
are credited and that the original publication in this journal is cited, in accordance
with accepted academic practice. No use, distribution or reproduction is permitted
which does not comply with these terms.
Frontiers in Neuroanatomy | www.frontiersin.org 17 April 2016 | Volume 10 | Article 39
